Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Importance of the Use of Omeprazole and Famotidine in the Development of Chronic Dysfunction of the Transplanted Kidney

NCT05061303 is registered in ClinicalTrials.gov with Poznan University of Medical Sciences as lead sponsor.

NCT NCT05061303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05061303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Importance of the Use of Omeprazole and Famotidine in the Development of Chronic Dysfunction of the Transplanted Kidney
Lead sponsor
Poznan University of Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
October 17, 2021
Completion date
June 30, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney rejection transplant